Purchase Order HHSN272201400105P
- Not listed
- This federal contract award, HHSN272201400545P, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Abbott Laboratories Inc. through its Abbott Diagnostics Division. The $12,383.00 firm-fixed-price purchase order is for the delivery of an RT HIV-1 AMP RGT KIT, catalog number 06L18-090. There was no set-aside designation for this contract. Abbott Laboratories, a global healthcare company, has a history of providing a...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order worth $125,096.60 to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV-1 control kits. The order has an anticipated completion date of August 25, 2022 and did not utilize any set-aside designations. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has previously supported federal customers such as the Department of...
- This is a federal contract award to Abbott Laboratories Inc., a subsidiary of the pharmaceutical and medical device company Abbott Laboratories, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $8,179.98 fixed-price purchase order was awarded on August 14, 2013, with a completion date of August 28, 2013. The contract did not have a set-aside designation. This contract is likely part of a broader Indefinite...
- This federal contract award is for the provision of HIV RNA extraction equipment, HIV amplification controls, calibrators, and related supplies. The contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The award has a ceiling value of $76,942.47 and a completion date of September 15, 2020. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA)...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide HIV molecular testing services. The contract is a Blanket Purchase Agreement (BPA) call from a Critical Analyzers, Laboratory GSA Schedule contract, with a firm fixed price pricing type. The potential value of the contract is $300,000.00, and it has a completion date of September 9, 2019. The contract does not have a...
- The Department of the Army Medical Command awarded Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a $30,980 firm fixed price call order against the Medical Products and Services Blanket Purchase Agreement for reagents and supplies in support of HIV-1 testing at the Walter Reed Army Institute of Research in Silver Spring, Maryland. No set-aside designation was applied to this contract, which has a period of performance through June 15, 2022. The call order will deliver test kits...
- This is a Blanket Purchase Agreement (BPA) call order awarded by the Medical Command (MEDCOM) component of the U.S. Department of the Army to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the VIROSEQ HIV-1 GT V2 KIT. The award has a firm fixed price of $91,102.00 and a performance period ending on August 12, 2015. The contract does not have a set-aside designation. Abbott Molecular is a manufacturer of diagnostic products and services that has previously provided a range of...
- This federal contract award was issued by the Veterans Integrated Service Network 21 (VISN 21), a component of the U.S. Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract, valued at $671,127.40, is for the provision of HIV and HCV molecular testing services and products. This award was made under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule contract, which is a Firm Fixed Price contract type. The contract does not have...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a firm fixed-price purchase order valued at $121,043.36 by the Centers for Disease Control and Prevention (CDC) on June 21, 2024, for delivery by February 1, 2025. The contract procures Abbott M2000 System equipment and related products from Abbott Molecular's Des Plaines, Illinois facility. The Abbott M2000 System is designated by the World Health Organization as the reference method for HIV viral load testing and early...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Abbott Laboratories Inc. for the procurement of three Piccolo Xpress Analyzers, with a total potential value of $42,024.40. The award was made under Simplified Acquisition Procedures without a set-aside, and the equipment will be delivered to the NIH facility in Frederick, Maryland. As a leading medical...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $8,858.00 firm-fixed-price purchase order is for RT-HIV-1 control kits, catalog number 06L18-080, for use by NIAID. The award has an ultimate completion date of January 3, 2014 and was made on December 3, 2013. This purchase order does not appear to be associated with a larger contract vehicle, and no set-aside designation is indicated. As a subsidiary of the global healthcare company Abbott Laboratories, Abbott Molecular provides a range of molecular diagnostic products and services to federal agencies, including the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Department of the Army, supporting their infectious disease testing and research needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($14) | 7/9/14 | |
| Not listed | Not listed | $8.9k | 12/3/13 |